{"id":"5a6e1897-ba23-4723-b9fb-74af95076026","kind":"companies","code":"UB-C3467","name":"Space Peptides","nameBasis":"source-english","summary":"Provider of AI healthcare service solutions","description":"Space Peptides provides AI healthcare service solutions.","country":"China","category":null,"originalName":"胜普泽泰","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-03T00:00:00.000Z","englishUpdatedAt":"2026-10-16T00:39:11.480Z","reviewedAt":"2026-10-16T00:39:11.480Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ea8599fea277ff34686264ba01a612fe7b2dc36fbf59d74ef3b2bd110e44b432","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"人工智能医疗服务解决方案提供商\n\n胜普泽泰是一家人工智能医疗服务解决方案提供商","sources":[],"related":[{"id":"e7c5a37c-745c-46d1-a32f-37c0c4462829","kind":"products","code":"UB-D411","name":"Shengpuzetai","nameBasis":"transliterated","summary":"Shengpu Zetai provides AI medical service solutions. Combining drug-structure big data with AI, it builds a one-stop AI-CRDMO platform for peptides, peptidomimetics and peptide-drug conjugates (PDC), spanning discovery (CRO) through industrial production (CMO/CDMO). Through joint development with pharmaceutical companies, it provides AI drug molecule design and synthesis, preclinical animal validation, patentable preclinical candidate compounds (PCC), and clinical applications for innovative drugs. It also supplies active pharmaceutical ingredients throughout clinical research and large-scale commercialization after approval.","description":"Shengpu Zetai provides AI medical service solutions. Combining drug-structure big data with AI, it builds a one-stop AI-CRDMO platform for peptides, peptidomimetics and peptide-drug conjugates (PDC), spanning discovery (CRO) through industrial production (CMO/CDMO). Through joint development with pharmaceutical companies, it provides AI drug molecule design and synthesis, preclinical animal validation, patentable preclinical candidate compounds (PCC), and clinical applications for innovative drugs. It also supplies active pharmaceutical ingredients throughout clinical research and large-scale commercialization after approval.","country":null,"category":"Health management","originalName":"胜普泽泰","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-11T18:07:15.824Z","englishUpdatedAt":"2026-10-16T00:49:11.065Z","reviewedAt":"2026-10-16T00:49:11.065Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"85f0dc956b0714bff74236cfbbeeaea2f9239f7f25f9d4516668dc742479b784","companyId":"5a6e1897-ba23-4723-b9fb-74af95076026","foundedYear":null,"logoUrl":null,"path":"/products/shengpuzetai"},{"id":"3aa43a6c-e722-4dea-ad31-e5ac6d59a955","kind":"news","code":"3aa43a6c-e722-4dea-ad31-e5ac6d59a955","name":"Space Peptides raises RMB 100 million in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"胜普泽泰完成1亿人民币A轮融资","eventDate":"2022-04-02T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:38:22.251Z","englishUpdatedAt":"2026-10-15T17:19:59.409Z","reviewedAt":"2026-10-15T17:19:59.409Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3d7fd31289c756d6a9c1ada08a16e01bf3561bc026bc98991dd5aa042ae2af14","companyId":"5a6e1897-ba23-4723-b9fb-74af95076026","foundedYear":null,"logoUrl":null,"path":"/news/3aa43a6c-e722-4dea-ad31-e5ac6d59a955"},{"id":"4b29ebe6-3331-47e4-aac0-639f8facc65b","kind":"institutions","code":"UB-I509","name":"同创伟业","nameBasis":"transliterated","summary":"A domestic Chinese well-known private equity firm.","description":"A domestic Chinese well-known private equity firm.","country":null,"category":null,"originalName":"同创伟业","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.676Z","englishUpdatedAt":"2026-10-15T18:21:17.050Z","reviewedAt":"2026-10-15T18:21:17.050Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"56d8f4d988399c9989d04de8c934cafc229fcfd718ad05539e4c5de9a02fa5d6","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Tongchuangweiye","path":"/institutions/tongchuangweiye"},{"id":"fb33d877-7bbd-40f6-93fb-871324e7f22b","kind":"institutions","code":"UB-I6106","name":"朝乾资本","nameBasis":"transliterated","summary":"Chaoqian Capital, a venture capital firm focused on technology investments.","description":"Chaoqian Capital, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"朝乾资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:25.311Z","englishUpdatedAt":"2026-10-15T17:35:40.043Z","reviewedAt":"2026-10-15T17:35:40.043Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0f9836a096b69344de0c28a8baf1bce8ec2c014b005dcbbfeedbdd1e30c476c2","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Chaoqian Capital","path":"/institutions/chaoqian-capital"},{"id":"910144e5-6038-4c01-b2da-e36222960de3","kind":"institutions","code":"UB-I6088","name":"永肽基金","nameBasis":"transliterated","summary":"Yongtai Fund, a venture capital firm focused on technology investments.","description":"Yongtai Fund, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"永肽基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:24.247Z","englishUpdatedAt":"2026-10-15T17:35:39.392Z","reviewedAt":"2026-10-15T17:35:39.392Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7dcf4ecc133e7ca6368e89fc3bac257d062524dc672024d511fc94269e70c92d","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Yongtai Fund","path":"/institutions/yongtai-fund"}],"finance":{"funding":{"metric":"funding","count":1,"latest":{"value":14285714,"text":"1亿人民币","date":"2022-04-02T00:00:00.000Z","round":"Series A","estimate":"RMB 100M"},"years":[2022],"points":[{"year":2022,"date":"2022-04-02T00:00:00.000Z","round":"Series A","value":14285714,"eventIds":["3aa43a6c-e722-4dea-ad31-e5ac6d59a955"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"3aa43a6c-e722-4dea-ad31-e5ac6d59a955","date":"2022-04-02T00:00:00.000Z","round":"Series A","amountText":"1亿人民币","estimateUsd":14285714,"estimateLabel":"RMB 100M","estimateNote":"≈ $14.3M","investors":"同创伟业,永肽基金,朝乾资本","institutions":[{"id":"4b29ebe6-3331-47e4-aac0-639f8facc65b","kind":"institutions","code":"UB-I509","name":"同创伟业","nameBasis":"transliterated","summary":"A domestic Chinese well-known private equity firm.","description":"A domestic Chinese well-known private equity firm.","country":null,"category":null,"originalName":"同创伟业","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.676Z","englishUpdatedAt":"2026-10-15T18:21:17.050Z","reviewedAt":"2026-10-15T18:21:17.050Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"56d8f4d988399c9989d04de8c934cafc229fcfd718ad05539e4c5de9a02fa5d6","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Tongchuangweiye","path":"/institutions/tongchuangweiye"},{"id":"fb33d877-7bbd-40f6-93fb-871324e7f22b","kind":"institutions","code":"UB-I6106","name":"朝乾资本","nameBasis":"transliterated","summary":"Chaoqian Capital, a venture capital firm focused on technology investments.","description":"Chaoqian Capital, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"朝乾资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:25.311Z","englishUpdatedAt":"2026-10-15T17:35:40.043Z","reviewedAt":"2026-10-15T17:35:40.043Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0f9836a096b69344de0c28a8baf1bce8ec2c014b005dcbbfeedbdd1e30c476c2","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Chaoqian Capital","path":"/institutions/chaoqian-capital"},{"id":"910144e5-6038-4c01-b2da-e36222960de3","kind":"institutions","code":"UB-I6088","name":"永肽基金","nameBasis":"transliterated","summary":"Yongtai Fund, a venture capital firm focused on technology investments.","description":"Yongtai Fund, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"永肽基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:24.247Z","englishUpdatedAt":"2026-10-15T17:35:39.392Z","reviewedAt":"2026-10-15T17:35:39.392Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7dcf4ecc133e7ca6368e89fc3bac257d062524dc672024d511fc94269e70c92d","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Yongtai Fund","path":"/institutions/yongtai-fund"}],"newsUrl":null,"evidence":{"headline":"Space Peptides raises RMB 100 million in Series A financing","brief":null,"basis":null,"newsPath":"/news/3aa43a6c-e722-4dea-ad31-e5ac6d59a955","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"3aa43a6c-e722-4dea-ad31-e5ac6d59a955","date":"2022-04-02T00:00:00.000Z","round":"Series A","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"同创伟业,永肽基金,朝乾资本","institutions":[{"id":"4b29ebe6-3331-47e4-aac0-639f8facc65b","kind":"institutions","code":"UB-I509","name":"同创伟业","nameBasis":"transliterated","summary":"A domestic Chinese well-known private equity firm.","description":"A domestic Chinese well-known private equity firm.","country":null,"category":null,"originalName":"同创伟业","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.676Z","englishUpdatedAt":"2026-10-15T18:21:17.050Z","reviewedAt":"2026-10-15T18:21:17.050Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"56d8f4d988399c9989d04de8c934cafc229fcfd718ad05539e4c5de9a02fa5d6","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Tongchuangweiye","path":"/institutions/tongchuangweiye"},{"id":"fb33d877-7bbd-40f6-93fb-871324e7f22b","kind":"institutions","code":"UB-I6106","name":"朝乾资本","nameBasis":"transliterated","summary":"Chaoqian Capital, a venture capital firm focused on technology investments.","description":"Chaoqian Capital, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"朝乾资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:25.311Z","englishUpdatedAt":"2026-10-15T17:35:40.043Z","reviewedAt":"2026-10-15T17:35:40.043Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0f9836a096b69344de0c28a8baf1bce8ec2c014b005dcbbfeedbdd1e30c476c2","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Chaoqian Capital","path":"/institutions/chaoqian-capital"},{"id":"910144e5-6038-4c01-b2da-e36222960de3","kind":"institutions","code":"UB-I6088","name":"永肽基金","nameBasis":"transliterated","summary":"Yongtai Fund, a venture capital firm focused on technology investments.","description":"Yongtai Fund, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"永肽基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:24.247Z","englishUpdatedAt":"2026-10-15T17:35:39.392Z","reviewedAt":"2026-10-15T17:35:39.392Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7dcf4ecc133e7ca6368e89fc3bac257d062524dc672024d511fc94269e70c92d","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Yongtai Fund","path":"/institutions/yongtai-fund"}],"newsUrl":null,"evidence":{"headline":"Space Peptides raises RMB 100 million in Series A financing","brief":null,"basis":null,"newsPath":"/news/3aa43a6c-e722-4dea-ad31-e5ac6d59a955","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"3aa43a6c-e722-4dea-ad31-e5ac6d59a955","kind":"funding","eventDate":"2022-04-02T00:00:00.000Z","revenueDate":null,"round":"A轮","amountText":"1亿人民币","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":14285714,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"同创伟业,永肽基金,朝乾资本","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"4b29ebe6-3331-47e4-aac0-639f8facc65b","kind":"institutions","code":"UB-I509","name":"同创伟业","nameBasis":"transliterated","summary":"A domestic Chinese well-known private equity firm.","description":"A domestic Chinese well-known private equity firm.","country":null,"category":null,"originalName":"同创伟业","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.676Z","englishUpdatedAt":"2026-10-15T18:21:17.050Z","reviewedAt":"2026-10-15T18:21:17.050Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"56d8f4d988399c9989d04de8c934cafc229fcfd718ad05539e4c5de9a02fa5d6","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Tongchuangweiye","path":"/institutions/tongchuangweiye"},{"id":"fb33d877-7bbd-40f6-93fb-871324e7f22b","kind":"institutions","code":"UB-I6106","name":"朝乾资本","nameBasis":"transliterated","summary":"Chaoqian Capital, a venture capital firm focused on technology investments.","description":"Chaoqian Capital, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"朝乾资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:25.311Z","englishUpdatedAt":"2026-10-15T17:35:40.043Z","reviewedAt":"2026-10-15T17:35:40.043Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0f9836a096b69344de0c28a8baf1bce8ec2c014b005dcbbfeedbdd1e30c476c2","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Chaoqian Capital","path":"/institutions/chaoqian-capital"},{"id":"910144e5-6038-4c01-b2da-e36222960de3","kind":"institutions","code":"UB-I6088","name":"永肽基金","nameBasis":"transliterated","summary":"Yongtai Fund, a venture capital firm focused on technology investments.","description":"Yongtai Fund, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"永肽基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:24.247Z","englishUpdatedAt":"2026-10-15T17:35:39.392Z","reviewedAt":"2026-10-15T17:35:39.392Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7dcf4ecc133e7ca6368e89fc3bac257d062524dc672024d511fc94269e70c92d","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Yongtai Fund","path":"/institutions/yongtai-fund"}],"roundName":"Series A","amountLabel":"RMB 100M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[{"id":"e7c5a37c-745c-46d1-a32f-37c0c4462829","kind":"products","code":"UB-D411","name":"Shengpuzetai","nameBasis":"transliterated","summary":"Shengpu Zetai provides AI medical service solutions. Combining drug-structure big data with AI, it builds a one-stop AI-CRDMO platform for peptides, peptidomimetics and peptide-drug conjugates (PDC), spanning discovery (CRO) through industrial production (CMO/CDMO). Through joint development with pharmaceutical companies, it provides AI drug molecule design and synthesis, preclinical animal validation, patentable preclinical candidate compounds (PCC), and clinical applications for innovative drugs. It also supplies active pharmaceutical ingredients throughout clinical research and large-scale commercialization after approval.","description":"Shengpu Zetai provides AI medical service solutions. Combining drug-structure big data with AI, it builds a one-stop AI-CRDMO platform for peptides, peptidomimetics and peptide-drug conjugates (PDC), spanning discovery (CRO) through industrial production (CMO/CDMO). Through joint development with pharmaceutical companies, it provides AI drug molecule design and synthesis, preclinical animal validation, patentable preclinical candidate compounds (PCC), and clinical applications for innovative drugs. It also supplies active pharmaceutical ingredients throughout clinical research and large-scale commercialization after approval.","country":null,"category":"Health management","originalName":"胜普泽泰","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-11T18:07:15.824Z","englishUpdatedAt":"2026-10-16T00:49:11.065Z","reviewedAt":"2026-10-16T00:49:11.065Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"85f0dc956b0714bff74236cfbbeeaea2f9239f7f25f9d4516668dc742479b784","companyId":"5a6e1897-ba23-4723-b9fb-74af95076026","foundedYear":null,"logoUrl":null,"path":"/products/shengpuzetai"}],"investors":[{"id":"4b29ebe6-3331-47e4-aac0-639f8facc65b","kind":"institutions","code":"UB-I509","name":"同创伟业","nameBasis":"transliterated","summary":"A domestic Chinese well-known private equity firm.","description":"A domestic Chinese well-known private equity firm.","country":null,"category":null,"originalName":"同创伟业","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.676Z","englishUpdatedAt":"2026-10-15T18:21:17.050Z","reviewedAt":"2026-10-15T18:21:17.050Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"56d8f4d988399c9989d04de8c934cafc229fcfd718ad05539e4c5de9a02fa5d6","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Tongchuangweiye","path":"/institutions/tongchuangweiye"},{"id":"fb33d877-7bbd-40f6-93fb-871324e7f22b","kind":"institutions","code":"UB-I6106","name":"朝乾资本","nameBasis":"transliterated","summary":"Chaoqian Capital, a venture capital firm focused on technology investments.","description":"Chaoqian Capital, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"朝乾资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:25.311Z","englishUpdatedAt":"2026-10-15T17:35:40.043Z","reviewedAt":"2026-10-15T17:35:40.043Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0f9836a096b69344de0c28a8baf1bce8ec2c014b005dcbbfeedbdd1e30c476c2","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Chaoqian Capital","path":"/institutions/chaoqian-capital"},{"id":"910144e5-6038-4c01-b2da-e36222960de3","kind":"institutions","code":"UB-I6088","name":"永肽基金","nameBasis":"transliterated","summary":"Yongtai Fund, a venture capital firm focused on technology investments.","description":"Yongtai Fund, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"永肽基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:24.247Z","englishUpdatedAt":"2026-10-15T17:35:39.392Z","reviewedAt":"2026-10-15T17:35:39.392Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7dcf4ecc133e7ca6368e89fc3bac257d062524dc672024d511fc94269e70c92d","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Yongtai Fund","path":"/institutions/yongtai-fund"}],"path":"/companies/shengpuzetai","structured":{"city":"Shanghai","country":"China","location":null,"role":null,"category":null,"company":null},"definition":"Space Peptides is a company in the Industry apps sector headquartered in Shanghai, China.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/companies/shengpuzetai"}